Some info - It's not a "new" generic, it's actually old, it's from the Purdue lawsuit over their patent a few years back, they have a contract to allow certain manufacturers to sell generic OC, but it's a quanitity amount only - so once it runs out its over. And they are only allowed to sell it to certain pharmacies, Walgreens being one. Other pharamcies can't even order it.

It's actually brand name "old" version OC (old meaning before this OP stuff) Ethex buys it from Purdue then sells it under their name. So you are getting brand med for generic price.

But again, they were only allowed to sell a certain quantity, and once that runs out, there will be no more generic, and then only the new OP will be on the market. So don't get too attached . . . . It is not likely to be around for much longer, expecially with the new OP being so unpopular. It was estimated a few months ago that the supply would run out in January 2010, but with the new mess, I would guess it will go much faster.

Here is the press release about Ethex and Purdue's settlement:

"ST. LOUIS, MO – June 9, 2009 - KV Pharmaceutical Company (NYSE: KVa/KVb) of St. Louis, MO., today announced it has entered into a settlement agreement with Purdue Pharma L.P. of Stamford, Conn., in regard to the patent infringement lawsuit between the two companies. Under the terms of the settlement agreement, KV Pharmaceutical Company acknowledges that Purdue Pharma’s OxyContin® patents are valid and enforceable and infringed. In exchange, Purdue will grant KV Pharmaceutical Company certain limited non-exclusive, royalty-bearing, non-transferable rights to sell in the United States generic versions of the drug OxyContin® (oxycodone HCl controlled-release) for a limited period of time. The Companies have agreed to continue to discuss the final location for the manufacturing of this product.

KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets, and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products. The Company markets its technology distinguished products through ETHEX Corporation, a subsidiary that competes with branded products, and Ther-Rx Corporation, the company's branded drug subsidiary."